Recital 7, Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requiremen…

In forcesince 8 Aug 2012

European and international scientific bodies, such as the European Medicines Agency [Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3) (OJ C 73, 5.3.2011, p. 1).], the European Food Safety Agency [http://www.efsa.europa.eu/en/topics/topic/bse.htm], the former Scientific Steering Committee [http://ec.europa.eu/food/fs/bse/scientific_advice08_en.print.html] and the former Scientific Committee on Medicinal Products and Medical Devices [See http://ec.europa.eu/health/scientific_committees/emerging/opinions/scmpmd/index_en.htm], adopted several opinions on specified risk materials and on minimising the risk of transmitting animal spongiform encephalopathy agents which are of relevance to the safety of medical devices.